EligibleTrials

Spanish Series of Patients Treated With the Radionuclide Lutetium177

Recruiting · NCT04949282 · Observational (researchers observe without assigning treatment) · Lead sponsor: Sociedad Española de Medicina Nuclear e Imagen Molecular

View the official record on ClinicalTrials.gov →
Pancreatic cancer

Interventions studied

Lutetium [177Lu] oxodotreotide/dotatate

What this trial is about

This study aims to pool the clinical experience of Spanish centers treating patients with 177Lu-DOTATATE to evaluate the efficacy, tolerance, and safety of the drug in routine clinical practice and to learn about the profiles of patients and tumors treated and the results in each type of patient and tumor.

Who can take part

Age range
18 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

20 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.